2017 annual financial data
Silence Therapeutics 2017 Operating margin
Direct answer
Operating margin was -89,943.75%.
Operating income was -14,391,000 GBP and net income was -1,618,000 GBP.
Operating cash flow was -9,599,000 GBP.
Get free Silence Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 16,000 GBP
- Operating income
- -14,391,000 GBP
- Net income
- -1,618,000 GBP
- Operating cash flow
- -9,599,000 GBP